Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
06/2010
06/09/2010CN101721706A Medicine composition containing matrine class alkaloid, preparation method and pharmaceutical application
06/09/2010CN101721705A Sleep-easy preparation- efficient endogenous physiological regulating control agent
06/09/2010CN101721704A Method and medicament for regulating glycogen content in liver cell
06/09/2010CN101721412A Methods of treating microbial infections in humans and animals
06/09/2010CN101721400A Action of ferulic acid on enhancing drug effect of some medicaments and purpose thereof
06/09/2010CN101721389A Method for preparing in-situ therapeutic substance-loaded microcapsules
06/09/2010CN101721368A Medicinal composition for aerosol
06/09/2010CN101721366A Components and preparation method of beta-lactam injection
06/09/2010CN101721354A Ocular implant made by a double extrusion process
06/09/2010CN101721353A Stable thermosensitive gelatin composite
06/09/2010CN101721352A Glass slow-release conduit of fat-soluble medicine
06/09/2010CN101390828B Anticancer composition loaded with anti-metabolism medicine and synergist thereof
06/09/2010CN101161236B Method of producing drug-carrying nanometer particle of complex coacervation technics in microemulsion
06/08/2010US7732588 Expression vector comprising nucleotide sequences coding tumor necrosis factor receptor protein (TWEAK) for mediated by angiogenesis, such as solid tumors and vascular deficiencies of cardiac or peripheral tissue
06/08/2010US7732584 Exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in cancers; provides a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer
06/08/2010US7732487 Administering calcium channel modulators such as 13,14-dihydro 15-keto-16,16-difluoroprostaglandin E1, for prophylaxis of brain, cardiovascular, gastrointerstinal, respiratory system, vision or liver disorders
06/08/2010US7732484 Use of selective adenosine A1 receptor allosteric enhancers to manipulate angiogenesis
06/08/2010US7732462 Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
06/08/2010US7732425 Comprises trehalose; for treatment of Gougerot-Sjogren Syndrome
06/08/2010US7732422 TRPM-2 antisense therapy
06/08/2010US7732415 Topical treatment or prevention of ocular infections
06/08/2010US7732201 neural cells comprising a neuroblast and a nestin-positive neural cell; for treating neuronal disorders
06/08/2010US7732200 Using chondroitin sulfate proteoglycan (CSPG)-degrading enzymes mixture to propagate nervous system tissue in culture for use as tissue targeted tools in treatment of brain and neurodegenerative disorders
06/08/2010US7732190 Mixture comprising a first functionalized polymer in a first buffer; a second buffer at approximately physiological osmolality; a second functionalized polymer, a substance having at least one cell-adhesion site combined with the first mixture
06/08/2010US7732146 Method for screening an agent that modulates activity of macrophage migration inhibitory factor
06/08/2010US7731989 Gastric retained gabapentin dosage form
06/08/2010US7731983 Method and composition for the treatment of scars
06/08/2010US7731973 Administering estriol to treat multiple sclerosis, autoimmune diseases, psoriasis, Sjogren's syndrome, encephalomyelitis; inflammatory bowel, Crohn's, Hashimoto's, or Addison's disease; diabetes, myasthenia gravis, lupus, rheumatoid arthritis, polymyositis; immunotherapy; magnetic resonance imaging
06/08/2010US7731967 Compositions for inducing immune responses
06/08/2010US7731953 inducing proliferation of CD4+ T cells using human thymic stromal derived lymphopoietin (TSLP) polypeptide; asthma or rhino-conjunctivitis
06/08/2010US7731951 Viruses for the treatment of cellular proliferative disorders
06/08/2010US7731950 Attack of tumor cells with missing, low or aberrant MHC expression by combining non MHC-restricted T-cells/NK-cells and MHC-restricted cells
06/08/2010US7731946 Methods and compositions for modulating T helper (TH) cell development and function
06/08/2010US7731945 Immunotherapy for reversing immune suppression
06/08/2010CA2458946C Composite staple for completing an anastomosis
06/08/2010CA2447178C Pharmaceutical composition for use in hormone replacement therapy
06/08/2010CA2440213C Method for improving the well-being of poultry by in-ovo injection of carnitine
06/08/2010CA2434972C Implantable device containing resorbable matrix material and anti-proliferative drugs for preventing or treating failure of hemodialysis vascular access and other vascular grafts
06/08/2010CA2433453C Triazolo[4,5-d]pyrimidine derivatives and their use as purinergic receptor antagonists
06/08/2010CA2431983C Novel 1,2-diphenylazetidinones, processes for their preparation, medicaments comprising these compounds and their use for treating impaired lipid metabolism
06/08/2010CA2429168C Method for restoring a damaged or degenerated intervertebral disc
06/08/2010CA2389300C 4-phenyl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
06/08/2010CA2383233C Surface modified particulate compositions of biologically active substances
06/08/2010CA2370019C Transdermal therapeutic system with neutralized acrylic pressure-sensitive adhesives
06/03/2010WO2010062692A1 Combination of morphinan compounds and antidepressant for the treatment of pseudobulbar affect, neurological diseases, intractable and chronic pain and brain injury
06/03/2010WO2010062690A1 Combination of morphinan compounds and antidepressant for the treatment of pseudobulbar affect, neurological diseases, intractable and chronic pain and brain injury
06/03/2010WO2010061907A1 Anti-cancer agent
06/03/2010WO2010061880A1 Vesicle preparation
06/03/2010WO2010061208A2 Therapeutic treatment 555
06/03/2010WO2010061142A2 Composition for slowing cancer cell tumor initiation in a high-risk mammal
06/03/2010WO2010060939A2 Combination of hsp90 and herceptin inhibitors
06/03/2010WO2010060937A2 Hsp90 inhibitor combinations
06/03/2010WO2009150405A8 Combinations of sapacitabine or cndac with dna methyltransferase inhibitors such as decitabine and procaine
06/03/2010US20100138947 Method for Producing Stem Cells or Stel Cell-Like Cells from Mammalian Embryos
06/03/2010US20100137940 Method for Directed Intranasal Administration of a Composition
06/03/2010US20100137583 Peptidomimetic protease inhibitors
06/03/2010US20100137431 Use of substances that act as cascade inhibitors of the raf/mek/erk signal cascade, for producing a medicament to treat dna and rna viruses
06/03/2010US20100137365 Long chain N-alkyl compounds and oxa-derivatives thereof
06/03/2010US20100137291 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
06/03/2010US20100137265 Treatment of conditions relating to hormone deficiencies by administration of progestins
06/03/2010US20100137251 Functional Role for Cannabinoids in Autonomic Stability During Sleep
06/03/2010US20100137238 Method For Increasing Hair Growth
06/03/2010US20100137232 Composition comprising a diuretic and a cardiac glycoside for the treatment of dna viral infections of the eye
06/03/2010US20100137208 Intratumorally administered lactoferrin in the treatment of malignantneoplasms and other hyperproliferative diseases
06/03/2010US20100137198 Pharmaceutical composition for topical application
06/03/2010US20100136623 Mutations in ion channels
06/03/2010US20100136581 Diagnosis and treatment of malignant neoplasms
06/03/2010US20100136577 Compositions and methods for detection and treatment of proliferative abnormalities associated with overexpression of human transketolase like-1 gene
06/03/2010US20100136522 Endogenous retroviruses up-regulated in prostate cancer
06/03/2010US20100136100 Removal promoters and inhibitor for apoptosis cells in vivo
06/03/2010US20100136020 Uses of il-174 antagonists for inhibiting a th2 immune response
06/03/2010US20100136017 Diagnostic tumor markers, drug screening for tumorigenesis inhibition, and compositions and methods for treatment of cancer
06/03/2010US20100136011 Antibodies that bind to obm
06/03/2010US20100136003 Uses of mammalian cytokine; related reagents
06/03/2010US20100135996 Monoclonal antibodies and fragment thereof directed against the human anti-mullerian hormone type ii receptor (amhr-ii)
06/03/2010US20100135989 Anti-hiv agents
06/03/2010US20100135988 Methods for identifying agents for preventing or treating proliferative diseases, and for inhibiting extracellular matrix or alpha1 type IV collagen
06/03/2010US20100135975 CD133 Epitopes
06/03/2010US20100135973 Microorganism Strain CRC2631 of Salmonella typhimurium and its Use as a Cancer Therapeutic
06/03/2010US20100135971 Probiotics in a pre- and/or post surgical environment
06/03/2010US20100135964 Tissue grafting method
06/03/2010US20100135962 Novel Bacteriophage and Antibacterial Composition Comprising the Same
06/03/2010US20100135952 Methods for the treatment of renal failure
06/03/2010CA2742743A1 Combination of hsp90 and herceptin inhibitors
06/02/2010EP2191718A1 Compounds and uses for the treatment of airway diseases and for the delivery of airway drugs
06/02/2010EP2190483A1 Method of reducing the effects of cytostatic drugs on bone marrow derived cells, and methods of screening
06/02/2010EP2190481A2 Methods to identify and enrich for populations of ovarian cancer stem cells and somatic ovarian stem cells and uses thereof
06/02/2010EP1817057B1 Sodium stibogluconate and il-2 for treating cancer
06/02/2010EP1483228B1 Nk1 antagonists
06/02/2010EP1449432B1 Nonhuman model animal of systemic lupus erythematosus
06/02/2010EP1352658B1 Preventives or remedies for endometriosis
06/02/2010DE102008059201A1 In situ präzipitierende Arzneistofflösungen In situ precipitating drug solutions
06/02/2010CN101720222A Drug having effect of promoting hepatocyte growth
06/02/2010CN101717410A Phosphorus-containing compounds & uses thereof
06/02/2010CN101716349A Medicine composite used for embolotherapy and acesodyne and preparation method thereof
06/02/2010CN101716344A Pholcodine-containing compound pharmaceutical preparation for treating cold
06/02/2010CN101716230A Complex preparation of stephanotis and antibiotic for treating infectious disease
06/02/2010CN101716219A Fragrant cinnamon oil medicine for burns and scalds
06/02/2010CN101385718B Osmotic pump preparation composition for treating hyperlipemia
06/02/2010CN101371820B Anticancer sustained-release agent containing methotrexate potentiating agent
1 ... 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 ... 1151